Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

205.40 -1.92 (-0.93%)

Streaming Delayed Price Updated: 2:06 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity ↗

July 10, 2025

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

Via Investor's Business Daily

Topics Intellectual Property

P/E Ratio Insights for Johnson & Johnson ↗

July 09, 2025

Via Benzinga

Johnson & Johnson's Outlook Clouded By $2 Billion Headwind ↗

July 09, 2025

Johnson & Johnson's 2025 outlook sees slight EPS and revenue upgrades, while headwinds from biosimilars and tariffs are expected to weigh on performance.

Via Benzinga

Topics World Trade

Johnson & Johnson (NYSE:JNJ) – A Reliable Dividend Stock Worth Considering ↗

July 09, 2025

Johnson & Johnson (NYSE:JNJ) offers a reliable 3.33% dividend yield with strong profitability and financial health, making it a solid pick for dividend investors.

Via Chartmill

Trump Threatens 200% Tariffs On Drug Imports, Says Big Pharma Will Get Some Time 'To Get Their Act Together' ↗

July 08, 2025

Pharmaceutical investors are being cautious, with concerns over potential supply disruptions, cost pressures, and uncertainty regarding policy implementation.

Via Stocktwits

Topics ETFs Economy Government

Johnson & Johnson Submits Supplemental Drug Application To FDA For Schizophrenia Drug Caplyta ↗

July 08, 2025

J&J gained access to Caplyta by the acquisition of Intra-Cellular Therapies, Inc., which was completed in April.

Via Stocktwits

Topics Government

FDA Issues Early Alert For Johnson & Johnson's Abiomed Heart Pump Controllers ↗

July 07, 2025

FDA issued an Early Alert for Abiomed's Automated Impella Controllers due to potential safety concerns following reports of 3 deaths.

Via Benzinga

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Dividend Stock Instead? ↗

July 07, 2025

Via The Motley Fool

Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report ↗

July 04, 2025

Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .

Via Benzinga

Topics Government

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 02, 2025

Via Benzinga

Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3% ↗

July 01, 2025

The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields.

Via Benzinga

Topics Stocks

Johnson & Johnson's Drug Discount Plan Gets Thrown Out In Court ↗

July 01, 2025

A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who argued it violated program intent.

Via Benzinga

July 01, 2025

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

FDA Flags Weight Loss Risk In ADHD Meds For Kids — J&J, Novartis Escape New Warning ↗

June 30, 2025

The updated label applies to extended-release stimulants prescribed off-label to children under six, following data showing higher drug exposure and side effect rates in that age group.

Via Stocktwits

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers ↗

June 30, 2025

FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader future access in oncology and autoimmune treatment.

Via Benzinga

Johnson & Johnson Is Great. Here's Why You Shouldn't Buy It. ↗

June 27, 2025

Via The Motley Fool

Topics Lawsuit Supply Chain

Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever ↗

June 26, 2025

Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.

Via The Motley Fool

How Earle Dickson Healed Wound Care With The Band-Aid ↗

June 26, 2025

When Earle Dickson (1892-1961) invented the Band-Aid, treatments for minor cuts and scrapes were dicey. He changed that.

Via Investor's Business Daily

5 Dividend Stocks Poised to Profit From the AI Efficiency Boom ↗

June 24, 2025

Via The Motley Fool

Topics Artificial Intelligence

Donald Trump Jr. Joins Mark Cuban In Slamming Elizabeth Warren on Healthcare Pricing ↗

June 21, 2025

Donald Trump Jr. has joined Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren's approach to healthcare pricing.

Via Benzinga

Topics Government

Johnson & Johnson Unusual Options Activity For June 20 ↗

June 20, 2025

Via Benzinga

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗

June 20, 2025

A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.

Via Benzinga

2 Dividend Stocks to Buy and Never Sell ↗

June 18, 2025

Via The Motley Fool

Topics Lawsuit

Peering Into Johnson & Johnson's Recent Short Interest ↗

June 17, 2025

Via Benzinga

Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions

June 17, 2025

Johnson & Johnson’s first quarter results reflected a steady performance, with the company surpassing Wall Street’s revenue and adjusted profit expectations. Management credited the diversified...

Via StockStory

Topics Earnings World Trade

Elizabeth Warren, Jan Schakowsky Reportedly Seek Answers From Pfizer, Amgen, And Others On Low Federal Tax Bills ↗

June 17, 2025

The Democratic lawmakers alleged that pharmaceutical companies avoided paying U.S. tax bills by shifting their profits to offshore subsidiaries in jurisdictions with significantly lower tax rates, such...

Via Stocktwits

Topics Government

Johnson & Johnson (NYSE:JNJ) - A Reliable Dividend Stock Worth Considering ↗

June 17, 2025

Johnson & Johnson (NYSE:JNJ) is a top dividend stock with a 3.32% yield, strong profitability, and a reliable payout history, making it a solid choice for income investors.

Via Chartmill

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead? ↗

June 13, 2025

Via The Motley Fool

Topics Lawsuit

If I Could Invest $1,000 in Any Growth Stock, It Would Be This One ↗

June 12, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

June 11, 2025

Steady growth and dividend increases over decades can make investors remarkably wealthy.

Via The Motley Fool

Topics Economy

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Johnson & Johnson (NY:JNJ)

All News about Johnson & Johnson

Starting at $3.75/week.

Subscribe Today